Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Notice that Interim Report 1 2023/24 will be published on September 20, 2023
Phase Holographic Imaging announces that the date for publication of Interim Report 1 2023/24 is September 20, 2023.
PHI AB annual general meeting moved to 27 October 2023
The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
BioStock: PHI links up with two regenerative medicine networks
BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
BioPhotonics article on how QPI advances Regenerative Medicine (Issue 07/08 2023)
The BioPhotonics July/August 2023 issue holds a feature article by PHI highlighting how HoloMonitor’s quantitative phase imaging (QPI) technology has the potential to propel regenerative medicine forward.
BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
Applied Sciences Special Issue: Novel Approaches of Digital Holographic Microscopy in Cell Biology
PHI CSO Kersti Alm invites you to join this Applied Sciences Special Issue highlighting Digital Holographic Microscopy in Cell Biology.
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
PHI visit WFIRM – Inside the World of Regenerative Medicine
PHI headed to the Wake Forest Institute for Regenerative Medicine (WFIRM) in Winston-Salem to visit, collaborate and attend the World Stem Cell Summit 2023.